Browsing by Subject "Chronic kidney disease"
Now showing items 1-11 of 11
-
AMP-activated protein kinase as a drug target in chronic kidney disease
( Bentham Science Publishers B.V. , 2018 , Article Review)Background: Chronic kidney disease (CKD) is a condition increasingly affecting millions of individuals worldwide and is ranked as the ninth leading cause of death in the United States. AMP-activated protein kinase (AMPK) ... -
Assessment of treatment burden and its impact on quality of life in dialysis-dependent and pre-dialysis chronic kidney disease patients
( Elsevier Inc. , 2021 , Article)Background The management of chronic kidney disease (CKD) and its complications places a significant burden on patients, resulting in impairment of their health-related quality of life (HR-QOL). Little is known about ... -
Chronic kidney diseases and the risk of colorectal cancer: A systematic review and meta-analysis
( Taylor and Francis Ltd. , 2023 , Article)Objective: We conducted this review to offer a comprehensive search and up-to-date overview of the currently available information about the probability risk of colorectal cancer among chronic kidney disease patients. ... -
Methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa for anemia in non-dialysis-dependent CKD: a systematic review
( Kluwer Academic Publishers , 2014 , Article Review)Background Anemia management in non-dialysis-dependent chronic kidney disease (CKD) patients is associated with cardiovascular and cost benefits, slows decline in renal function, and prevents mortality. Different reviews ... -
Pill-burden and its association with treatment burden among patients with advanced stages of chronic kidney disease
( Elsevier , 2023 , Article)IntroductionChronic kidney disease (CKD) is associated with multimorbidity and high treatment burden. Pill-burden is one component of the overall treatment burden. However, little is known about its magnitude and contribution ... -
Pill-burden and its association with treatment burden among patients with advanced stages of chronic kidney disease
( Elsevier , 2023 , Article)Introduction: Chronic kidney disease (CKD) is associated with multimorbidity and high treatment burden. Pill-burden is one component of the overall treatment burden. However, little is known about its magnitude and ... -
Protein glycation – biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine
( Elsevier , 2021 , Article)Protein glycation provides a biomarker in widespread clinical use, glycated hemoglobin HbA1c (A1C). It is a biomarker for diagnosis of diabetes and prediabetes and of medium-term glycemic control in patients with established ... -
Quantifying Gut Microbiome in Rats with Adenine-Induced Chronic Kidney Disease and the Effect of Treatment with Gum Arabic
( Qatar University Press , 2020 , Poster)Chronic kidney disease (CKD) affects ~10% of Qatar's population. Recently, dysbiosis in the gut microbiome has been associated with CKD. It is not understood whether CKD affects the gut microbiome or the dysbiotic gut ... -
Structure–activity relationship of piperine and its synthetic amide analogs for therapeutic potential to prevent experimentally induced ER stress in vitro
( Springer Netherlands , 2017 , Article)Endoplasmic reticulum (ER) is the key organelle involved in protein folding and maturation. Emerging studies implicate the role of ER stress in the development of chronic kidney disease. Thus, there is an urgent need for ... -
A theoretically based cross-sectional survey on the behaviors and experiences of clinical pharmacists caring for patients with chronic kidney disease
( Elsevier , 2021 , Article)The literature shows a lack of evidence on pharmacists contributing to chronic kidney disease services. The aim was to determine pharmacists’ behaviors and experiences and perceptions of barriers and facilitators to ... -
What is Polypharmacy in Patients with Chronic Kidney Disease? A Systematic Review
( Elsevier , 2023 , Article)PurposePolypharmacy presents an increasing therapeutic challenge for physicians managing patients with chronic kidney disease (CKD). However, there is a lack of consensus regarding the specific medication count threshold ...